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ABSTRACT 
African Swine Fever (ASF) is a highly contagious, viral disease of pigs 
caused by an Asfivirus. It can cause up to 100% of mortality in domestic 
pigs and European wild boars, although varying degrees of virulence have 
been shown. In contrast, the infection is unapparent in African wild suids 
(warthogs, bushpigs, giant forest hogs). There is no treatrnent or vaccine to 
control this severe disease. To address this issue, we are currently working 
on the development of an attenuated vaccine and new generation of 
biological antivirals. For the generation of attenuated ASFV vaccine strains, 
we envisage to delete the 10 Kb region located 23638-33336 in the genome, 
which includes nine genes that are thought to determine the virulence of 
ASFV. Of these 9 genes, 4 (A104R, A118R, A151R and A240L) have 
unknown function in the virus replication cycle. To establish the importance 
of these genes, we have used the RNA interference approach. RNA 
interference is a natural biological process initially described in plants [Fire 
and Mello in 1998]. It a natural cell mechanism by which small interfering 
RNAs (siRNAs) of about 20 nucleotides operate to downregulate the 
expression of a gene by targeting and cleaving its mRNA (post-
transcriptional gene silencing). The 4 ASFV genes of a Spanish strain 
isolated in 1971 (Ba 71 v) were cloned and sequenced. The sequences were 
checked and compared with the reference sequence available in GenBank 
(accession nurnber ASU18466) before to be sent to Arnbion for siRNA 
design. We initially received 17 siRNAs from Arnbion of which, 3 were 
directed against each of the 4 genes of interest and 5 were directed against 
B646L encoding the essential viral capsid protein (contrai of siRNA 
efficacy). Prelirninary results of the siRNA evaluation indicate that A151R 
and as expected B646L, are essential genes for virus replication. 
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